Dr Reddy's Laboratories is planning to launch several value-added products this fiscal in the US market to offset the persisting problem. Moreover, the company is also planning to re-focus some of its Research and Development resources to service the high potential branded generics markets such as China, Russia and other emerging markets. As many as 110 generic filings awaiting approval from the USFDA and the company has to leverage this and ensure that they succeed in delivering these products, molecule by molecule, to the US on the due dates.
Dr. Reddy's Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.
